There is a shift from evidence-based medicine to reliance on expert guidance which must be balanced with the ethical risks of issuing no guidance at all during the coronavirus disease-2019 (COVID-19) pandemic, according to a letter to the editor published in the Journal of the American Academy of Dermatology.

The authors discuss the need for flexibility about guideline generation during the COVID-19 outbreak.